A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma
Clinical trial NCT05576272 · UNKNOWN
Trial details
- NCT number
- NCT05576272
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-19
- Primary completion
- 2024-12-30
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.